Close Menu
healthylife7.comhealthylife7.com

    Subscribe to Updates

    Get the latest creative news from FooBar about art, design and business.

    What's Hot

    What the $10B Crinetics Deal & $2.9B Soleno Acquisition Might Say About Palatin’s Rare

    July 22, 2026

    The Power Of Little Treats: Why You Should Spend $5 On Joy This Week

    July 22, 2026

    Statins Linked to Lower HCC, Hepatic Decompensation Risk in Chronic Liver Disease

    July 22, 2026
    Facebook X (Twitter) Instagram
    Trending
    • What the $10B Crinetics Deal & $2.9B Soleno Acquisition Might Say About Palatin’s Rare
    • The Power Of Little Treats: Why You Should Spend $5 On Joy This Week
    • Statins Linked to Lower HCC, Hepatic Decompensation Risk in Chronic Liver Disease
    • How Obesity Shapes Outcomes in Psoriatic Arthritis
    • Allies unite for Exercise Death Strike: Trident Fury
    • Turning pizza into a protein
    • Survey: Hamilton County women say healthcare, community and fair pay are top concerns
    • Obesity More Likely for Immigrants With Longer Duration of US Residence
    Facebook X (Twitter) Instagram
    healthylife7.comhealthylife7.com
    • Home
    • Fitness
    • Health
    • Nutrition
    • Lifestyle
    • Conditions
    • Mental Health
    • Weight Loss
    • Wellness Tips
    Wednesday, July 22
    healthylife7.comhealthylife7.com
    Home»Fitness»Palladyne AI Announces U.S. Air Force Exercise of Additional $2.9 Million STRATFI Contract Option Using Palladyne IQ Embodied AI Architecture for Autonomous Robotic Systems, Bringing Total Award to $10.6 Million
    Fitness

    Palladyne AI Announces U.S. Air Force Exercise of Additional $2.9 Million STRATFI Contract Option Using Palladyne IQ Embodied AI Architecture for Autonomous Robotic Systems, Bringing Total Award to $10.6 Million

    healthylife7By healthylife7July 22, 2026No Comments3 Mins Read
    Facebook Twitter Pinterest LinkedIn Tumblr Reddit WhatsApp Email
    Palladyne AI Announces U.S. Air Force Exercise of Additional $2.9 Million STRATFI Contract Option Using Palladyne IQ Embodied AI Architecture for Autonomous Robotic Systems, Bringing Total Award to $10.6 Million
    Share
    Facebook Twitter LinkedIn Pinterest WhatsApp Email

    This is a paid press release. Contact the press release distributor directly with any inquiries.

    Palladyne AI Announces U.S. Air Force <a href="https://healthylife7.com/combat-readiness-exercise-2026-at-camp-atterbury/” title=”Combat Readiness Exercise 2026 at Camp Atterbury”>Exercise of Additional $2.9 Million STRATFI Contract Option Using Palladyne IQ Embodied AI Architecture for Autonomous Robotic Systems, Bringing Total Award to $10.6 Million


    Business Wire
    Wed, July 22, 2026 at 4:30 PM GMT+5:30
    5 min read

    • PDYN
      +4.79%

    SALT LAKE CITY, July 22, 2026–(BUSINESS WIRE)–Palladyne AI (NASDAQ: PDYN), a U.S.-based defense and industrial technology company delivering embodied AI-powered collaborative autonomy solutions, advanced avionics, precision-manufactured components, UAVs, and advanced aerospace engineering services, today announced that the U.S. Air Force has exercised a contractual option on its STRATFI (Strategic Funding Increase) contract, adding $2.9 million in new funding and increasing the total contract value to over $10.6 million. The option exercise reflects the Air Force’s continued satisfaction with the performance and progress of Palladyne AI’s Palladyne IQ™ embodied AI architecture for autonomous robotic systems.

    Ben Wolff, President and Chief Executive Officer of Palladyne AI, commented:“This option exercise is exactly the kind of milestone we set out to achieve. When a customer like the U.S. Air Force commits nearly $3 million more after seeing your technology perform, that is an unambiguous signal. Palladyne IQ’s AI architecture is working. The Air Force is a demanding customer operating in complex, real-world environments, and it has extended the contract. We believe this program is the proof point for what Palladyne IQ and its architecture can do at scale, and for the enormous market opportunity that lies ahead in autonomous defense robotics.”

    The STRATFI program, formally titled “Cybernetic Training for Autonomous Robots – Human Augmentation,” was originally awarded in September 2023. Since then, the Air Force has increased its investment as the technology has matured and demonstrated results, including completion of the first phase in October 2024 and additional funding in April 2025. This latest option exercise continues that pattern of performance-driven reinvestment

    The newly obligated funding covers a set of advanced demonstration milestones, including:

    • Human-guided machine learning on real robotic platforms, enabling robots to learn complex manipulation tasks autonomously with minimal demonstrations

    • Mixed-reality teleoperation enabling seamless collaboration between human operators and remote subject matter experts

    • Autonomous task execution on robotic platforms in Air Force-relevant mission scenarios

    Palladyne IQ is Palladyne AI’s flagship embodied AI platform, purpose-built to deliver closed-loop autonomy for robotic systems operating in dynamic, unstructured, and contested environments. Unlike conventional automation, Palladyne IQ enables robots to learn from as few as one to five human demonstrations, generalize that learning across variations in environment and task, and execute autonomously without cloud connectivity, a critical capability for defense applications where communications may be degraded or denied.

    Additional Announces exercise Force Palladyne
    healthylife7
    • Website

    Related Posts

    Allies unite for Exercise Death Strike: Trident Fury

    July 22, 2026

    Is Philadelphia one of the fittest cities? Here’s what the ACSM says

    July 22, 2026

    USS Theodore Roosevelt deploys ADDiTEC HYBRiD-X system in Exercise Rim of the Pacific 2026

    July 22, 2026
    Leave A Reply Cancel Reply

    Health
    Wellness Tips

    What the $10B Crinetics Deal & $2.9B Soleno Acquisition Might Say About Palatin’s Rare

    By healthylife7July 22, 20260

    Ten billion dollars. That is what Vertex Pharmaceuticals (Nasdaq: VRTX) agreed to pay on July 6, 2026, to acquire Crinetics Pharmaceuticals (Nasdaq: CRNX) at $85.00 per share, roughly a 101% premium to the prior close

    The Power Of Little Treats: Why You Should Spend $5 On Joy This Week

    July 22, 2026

    Statins Linked to Lower HCC, Hepatic Decompensation Risk in Chronic Liver Disease

    July 22, 2026

    How Obesity Shapes Outcomes in Psoriatic Arthritis

    July 22, 2026
    Stay In Touch
    • Facebook
    • Twitter
    • Pinterest
    • Instagram
    • YouTube
    • Vimeo
    Fitness

    Opinion: The FDA must put biotech at its center or continue to cede early research to China

    July 6, 2026

    Inside Elevance’s digital chronic disease management strategy

    July 6, 2026

    Best, Worst States For Well

    July 6, 2026

    What do the Middle Ages tell us about mental health then and now? VCU historian Leigh Ann Craig has answers

    July 6, 2026

    Subscribe to Updates

    Get the latest creative news from SmartMag about art & design.

    About Us

    Welcome to HealthyLife7.com, your trusted source for reliable health, wellness, fitness, and lifestyle information. Our mission is to help people make informed decisions about their health by providing clear, practical, and easy-to-understand content.

    At HealthyLife7.com, we believe that good health starts with the right knowledge. Whether you're looking for healthy eating tips, fitness advice, mental wellness strategies, weight management guidance, or information about common health conditions, our goal is to deliver valuable content that supports a healthier lifestyle.

    Fitness

    What the $10B Crinetics Deal & $2.9B Soleno Acquisition Might Say About Palatin’s Rare

    July 22, 2026

    The Power Of Little Treats: Why You Should Spend $5 On Joy This Week

    July 22, 2026

    Statins Linked to Lower HCC, Hepatic Decompensation Risk in Chronic Liver Disease

    July 22, 2026
    Health

    Opinion: The FDA must put biotech at its center or continue to cede early research to China

    July 6, 2026

    Inside Elevance’s digital chronic disease management strategy

    July 6, 2026

    Best, Worst States For Well

    July 6, 2026
    Facebook X (Twitter) Instagram Pinterest
    • About Us
    • Contact us
    • Disclaimer
    • Privacy Policy
    • Terms and Conditions
    © 2026 healthylife7.com. Designed by Pro.

    Type above and press Enter to search. Press Esc to cancel.